Peptides that inhibit HIV-1 integrase by blocking its protein-protein interactions

FEBS Journal

Volumn 279, Issue 16, 2012, Pages 2795-2809

  Maes, Michal ^a   Loyter, Abraham ^a   Friedler, Assaf ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

AIDS; HIV 1 integrase; peptide inhibitors; peptides

Indexed keywords

CELL PROTEIN; COMPLEMENTARY DNA; COMPLESTATIN; EBR28 PEPTIDE; IN 1 10 PEPTIDE; IN 11 20 PEPTIDE; IN 123 133 PEPTIDE; IN 129 139 PEPTIDE; IN 147 175 PEPTIDE; IN 196 210 PEPTIDE; IN 82 89 PEPTIDE; IN 93 107 PEPTIDE; IN 95 109 PEPTIDE; IN 97 102 PEPTIDE; IN 97 108 PEPTIDE; INDOLICIDIN; INTEGRAMIDE A; INTEGRAMIDE B; INTEGRASE; INTEGRASE INHIBITOR; LENS EPITHELIUM DERIVED GROWTH FACTOR; MARINE PEPTIDE DERIVATIVE; NATURAL PRODUCT; PEPTIDE DERIVATIVE; PROTEIN P75; REV PROTEIN; RIN 25 PEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS DNA; VPR PROTEIN;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IC 50; NONHUMAN; OLIGOMERIZATION; PEPTIDE LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG EVALUATION, PRECLINICAL; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; HIV REVERSE TRANSCRIPTASE; HUMANS; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PEPTIDES; PROTEIN MULTIMERIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84864413373     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08680.x     Document Type: Article

References (114)

1. Kaushik-Basu N, Basu A, &, Harris D, (2008) Peptide inhibition of HIV-1: current status and future potential. BioDrugs 22, 161-175. (Pubitemid 351692846)
2. Joly V, Jidar K, Tatay M, &, Yeni P, (2010) Enfuvirtide: from basic investigations to current clinical use. Expert Opin Pharmacother 11, 2701-2713.
3. Serrao E, Odde S, Ramkumar K, &, Neamati N, (2009) Raltegravir, elvitegravir, and metoogravir: the birth of 'me-too' HIV-1 integrase inhibitors. Retrovirology 6, 25. doi:10.1186/1742-4690-6-25.
4. Sherman MP, &, Greene WC, (2002) Slipping through the door: HIV entry into the nucleus. Microbes Infect 4, 67-73. (Pubitemid 34127993)
5. LaFemina RL, Schneider CL, Robbins HL, Callahan PL, LeGrow K, Roth E, Schleif WA, &, Emini EA, (1992) Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J Virol 66, 7414-7419.
6. Engelman A, Mizuuchi K, &, Craigie R, (1991) HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer. Cell 67, 1211-1221. (Pubitemid 121001533)
7. Craigie R, (2001) HIV integrase, a brief overview from chemistry to therapeutics. J Biol Chem 276, 23213-23216.
8. Van Maele B, Busschots K, Vandekerckhove L, Christ F, &, Debyser Z, (2006) Cellular co-factors of HIV-1 integration. Trends Biochem Sci 31, 98-105. (Pubitemid 43221842)
9. Guiot E, Carayon K, Delelis O, Simon F, Tauc P, Zubin E, Gottikh M, Mouscadet J, Brochon J, &, Deprez E, (2006) Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity. J Biol Chem 281, 22707-22719.
10. Chen A, Weber IT, Harrison RW, &, Leis J, (2006) Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat ends. J Biol Chem 281, 4173-4182. (Pubitemid 43847845)
11. Deprez E, Tauc P, Leh H, Mouscadet JF, Auclair C, &, Brochon JC, (2000) Oligomeric states of the HIV-1 integrase as measured by time-resolved fluorescence anisotropy. Biochemistry 39, 9275-9284. (Pubitemid 30626319)
12. Faure A, Calmels C, Desjobert C, Castroviejo M, Caumont-Sarcos A, Tarrago-Litvak L, Litvak S, &, Parissi V, (2005) HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res 33, 977-986. (Pubitemid 41430518)
13. Yoder KE, &, Bushman FD, (2000) Repair of gaps in retroviral DNA integration intermediates. J Virol 74, 11191-11200. (Pubitemid 32223986)
14. Cai M, Huang Y, Caffrey M, Zheng R, Craigie R, Clore GM, &, Gronenborn AM, (1998) Solution structure of the His12 - >Cys mutant of the N-terminal zinc binding domain of HIV-1 integrase complexed to cadmium. Protein Sci 7, 2669-2674. (Pubitemid 28565709)
15. Goldgur Y, Dyda F, Hickman AB, Jenkins TM, Craigie R, &, Davies DR, (1998) Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc Natl Acad Sci USA 95, 9150-9154. (Pubitemid 28506200)
16. Lodi PJ, Ernst JA, Kuszewski J, Hickman AB, Engelman A, Craigie R, Clore GM, &, Gronenborn AM, (1995) Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry, 34, 9826-9833.
17. Goldgur Y, Craigie R, Cohen GH, Fujiwara T, Yoshinaga T, Fujishita T, Sugimoto H, Endo T, Murai H, &, Davies DR, (1999) Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc Natl Acad Sci USA 96, 13040-13043.
18. Wang JY, Ling H, Yang W, &, Craigie R, (2001) Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J 20, 7333-7343. (Pubitemid 34062324)
19. Chen JC, Krucinski J, Miercke LJ, Finer-Moore JS, Tang AH, Leavitt AD, &, Stroud RM, (2000) Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc Natl Acad Sci USA 97, 8233-8238. (Pubitemid 30639655)
20. McKee CJ, Kessl JJ, Shkriabai N, Dar MJ, Engelman A, &, Kvaratskhelia M, (2008) Dynamic modulation of HIV-1 integrase structure and function by cellular LEDGF protein. J Biol Chem 283, 31802-31812.
21. Sluis-Cremer N, &, Tachedjian G, (2002) Modulation of the oligomeric structures of HIV-1 retroviral enzymes by synthetic peptides and small molecules. Eur J Biochem 269, 5103-5111. (Pubitemid 35340819)
22. Karki RG, Tang Y, Burke TR Jr, &, Nicklaus MC, (2004) Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design. J Comput Aided Mol Des 18, 739-760. (Pubitemid 40973864)
23. Hare S, Gupta SS, Valkov E, Engelman A, &, Cherepanov P, (2010) Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 464, 232-236.
24. Krishnan L, Li X, Naraharisetty HL, Hare S, Cherepanov P, &, Engelman A, (2010) Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc Natl Acad Sci USA 107, 15910-15915.
25. Cherepanov P, Ambrosio AL, Rahman S, Ellenberger T, &, Engelman A, (2005) Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc Natl Acad Sci USA 102, 17308-17313. (Pubitemid 41740862)
26. Turlure F, Devroe E, Silver PA, &, Engelman A, (2004) Human cell proteins and human immunodeficiency virus DNA integration. Front Biosci 9, 3187-3208.
27. Al-Mawsawi LQ, &, Neamati N, (2007) Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy. Trends Pharmacol Sci 28, 526-535. (Pubitemid 47488505)
28. Cherepanov P, Maertens G, Proost P, Devreese B, Van Beeumen J, Engelborghs Y, De Clercq E, &, Debyser Z, (2003) HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 278, 372-381. (Pubitemid 36043586)
29. De Luca L, Ferro S, Morreale F, De Grazia S, &, Chimirri A, (2011) Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75. ChemMedChem, 6, 1184-1191.
30. Ghosh RK, Ghosh SM, &, Chawla S, (2011) Recent advances in antiretroviral drugs. Expert Opin Pharmacother 12, 31-46.
31. Walker MA, (2009) New approaches for inhibiting HIV integrase: a journey beyond the active site. Curr Opin Investig Drugs 10, 129-136.
32. Al-Mawsawi LQ, Fikkert V, Dayam R, Witvrouw M, Burke TR Jr, Borchers CH, &, Neamati N, (2006) Discovery of a small-molecule HIV-1 integrase inhibitor-binding site. Proc Natl Acad Sci USA 103, 10080-10085. (Pubitemid 43993626)
33. Du L, Zhao Y, Chen J, Yang L, Zheng Y, Tang Y, Shen X, &, Jiang H, (2008) D77, one benzoic acid derivative, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular LEDGF/p75. Biochem Biophys Res Commun 375, 139-144.
34. De Luca L, Barreca ML, Ferro S, Christ F, Iraci N, Gitto R, Monforte AM, Debyser Z, &, Chimirri A, (2009) Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. ChemMedChem, 4, 1311-1316.
35. Christ F, Voet A, Marchand A, Nicolet S, Desimmie BA, Marchand D, Bardiot D, Van der Veken NJ, Van Remoortel B, Strelkov SV, et al., (2012) Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. Nat Chem Biol 6, 442-448.
36. Al-Mawsawi LQ, &, Neamati N, (2011) Allosteric inhibitor development targeting HIV-1 integrase. ChemMedChem, 6, 228-241.
37. Kalpana GV, Marmon S, Wang W, Crabtree GR, &, Goff SP, (1994) Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science, 266, 2002-2006.
38. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, &, Delattre O, (1998) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203-206. (Pubitemid 28325977)
39. Imbalzano AN, &, Jones SN, (2005) Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability. Cancer Cell 7, 294-295. (Pubitemid 40544646)
40. Vries RG, Bezrookove V, Zuijderduijn LM, Kia SK, Houweling A, Oruetxebarria I, Raap AK, &, Verrijzer CP, (2005) Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev 19, 665-670. (Pubitemid 40395077)
41. Maroun M, Delelis O, Coadou G, Bader T, Segeral E, Mbemba G, Petit C, Sonigo P, Rain JC, Mouscadet JF, et al., (2006) Inhibition of early steps of HIV-1 replication by SNF5/Ini1. J Biol Chem 281, 22736-22743.
42. Yung E, Sorin M, Pal A, Craig E, Morozov A, Delattre O, Kappes J, Ott D, &, Kalpana GV, (2001) Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nat Med 7, 920-926. (Pubitemid 32756429)
43. Tasara T, Maga G, Hottiger MO, &, Hubscher U, (2001) HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other. FEBS Lett 507, 39-44. (Pubitemid 33000295)
44. Bischerour J, Tauc P, Leh H, de Rocquigny H, Roques B, &, Mouscadet JF, (2003) The (52-96) C-terminal domain of Vpr stimulates HIV-1 IN-mediated homologous strand transfer of mini-viral DNA. Nucleic Acids Res 31, 2694-2702. (Pubitemid 37448473)
45. de Rocquigny H, Petitjean P, Tanchou V, Decimo D, Drouot L, Delaunay T, Darlix JL, &, Roques BP, (1997) The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J Biol Chem 272, 30753-30759. (Pubitemid 27527511)
46. Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, &, Emerman M, (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 91, 7311-7315. (Pubitemid 24226853)
47. Tung HY, De Rocquigny H, Zhao LJ, Cayla X, Roques BP, &, Ozon R, (1997) Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr. FEBS Lett 401, 197-201. (Pubitemid 27056115)
48. Rosenbluh J, Hayouka Z, Loya S, Levin A, Armon-Omer A, Britan E, Hizi A, Kotler M, Friedler A, &, Loyter A, (2007) Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides. J Biol Chem 282, 15743-15753. (Pubitemid 47093277)
49. Hazuda DJ, Young SD, Guare JP, Anthony NJ, Gomez RP, Wai JS, Vacca JP, Handt L, Motzel SL, Klein HJ, et al., (2004) Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. Science 305, 528-532. (Pubitemid 38971345)
50. Lataillade M, &, Kozal MJ, (2006) The hunt for HIV-1 integrase inhibitors. AIDS Patient Care STDS 20, 489-501. (Pubitemid 44078768)
51. Pommier Y, Johnson AA, &, Marchand C, (2005) Integrase inhibitors to treat HIV/AIDS. Nat Rev Drug Discov 4, 236-248. (Pubitemid 40372557)
52. Vandekerckhove L, (2010) GSK-1349572, a novel integrase inhibitor for the treatment of HIV infection. Curr Opin Investig Drugs 11, 203-212.
53. Chen X, Tsiang M, Yu F, Hung M, Jones GS, Zeynalzadegan A, Qi X, Jin H, Kim CU, Swaminathan S, et al., (2008) Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors. J Mol Biol 380, 504-519. (Pubitemid 351815132)
54. Barreca ML, Iraci N, De Luca L, &, Chimirri A, (2009) Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors. ChemMedChem 4, 1446-1456.
55. Johnson BC, Metifiot M, Pommier Y, &, Hughes SH, (2012) Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity. Antimicrob Agents Chemother 56, 411-419.
56. Pandey KK, &, Grandgenett DP, (2008) HIV-1 integrase strand transfer inhibitors: novel insights into their mechanism of action. Retrovirology 2, 11-16.
57. Camarasa MJ, Velazquez S, San-Felix A, Perez-Perez MJ, &, Gago F, (2006) Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes? Antiviral Res 71, 260-267. (Pubitemid 44223776)
58. Sourgen F, Maroun RG, Frere V, Bouziane M, Auclair C, Troalen F, &, Fermandjian S, (1996) A synthetic peptide from the human immunodeficiency virus type-1 integrase exhibits coiled-coil properties and interferes with the in vitro integration activity of the enzyme. Correlated biochemical and spectroscopic results. Eur J Biochem 240, 765-773. (Pubitemid 26321183)
59. Krebs D, Maroun RG, Sourgen F, Troalen F, Davoust D, &, Fermandjian S, (1998) Helical and coiled-coil-forming properties of peptides derived from and inhibiting human immunodeficiency virus type 1 integrase assessed by 1H-NMR-use of NH temperature coefficients to probe coiled-coil structures. Eur J Biochem 253, 236-244. (Pubitemid 28182326)
60. Maroun RG, Krebs D, El Antri S, Deroussent A, Lescot E, Troalen F, Porumb H, Goldberg ME, &, Fermandjian S, (1999) Self-association and domains of interactions of an amphipathic helix peptide inhibitor of HIV-1 integrase assessed by analytical ultracentrifugation and NMR experiments in trifluoroethanol/H(2)O mixtures. J Biol Chem 274, 34174-34185. (Pubitemid 129511755)
61. Maroun RG, Gayet S, Benleulmi MS, Porumb H, Zargarian L, Merad H, Leh H, Mouscadet JF, Troalen F, &, Fermandjian S, (2001) Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers. Biochemistry 40, 13840-13848. (Pubitemid 33078852)
62. Demeulemeester J, Tintori C, Botta M, Debyser Z, &, Christ F, (2012) Development of an AlphaScreen-based HIV-1 integrase dimerization assay for discovery of novel allosteric inhibitors. J Biomol Screen 17, 618-628.
63. Kong R, Wang C, Ma X, Liu J, &, Chen W, (2005) Peptides design based on the interfacial helix of integrase dimer. Conf Proc IEEE Eng Med Biol Soc 5, 4743-4746. (Pubitemid 46230005)
64. Zhao L, O'Reilly MK, Shultz MD, &, Chmielewski J, (2003) Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. Bioorg Med Chem Lett 13, 1175-1177. (Pubitemid 36331825)
65. Li HY, Zawahir Z, Song LD, Long YQ, &, Neamati N, (2006) Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme. J Med Chem 49, 4477-4486. (Pubitemid 44162674)
66. Ciuffi A, Llano M, Poeschla E, Hoffmann C, Leipzig J, Shinn P, Ecker JR, &, Bushman F, (2005) A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11, 1287-1289. (Pubitemid 41752906)
67. Llano M, Vanegas M, Fregoso O, Saenz D, Chung S, Peretz M, &, Poeschla EM, (2004) LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J Virol 78, 9524-9537. (Pubitemid 39096559)
68. Vandegraaff N, Devroe E, Turlure F, Silver PA, &, Engelman A, (2006) Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication. Virology, 346, 415-426. (Pubitemid 43357885)
69. Llano M, Delgado S, Vanegas M, &, Poeschla EM, (2004) Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J Biol Chem 279, 55570-55577. (Pubitemid 40066560)
70. Llano M, Saenz DT, Meehan A, Wongthida P, Peretz M, Walker WH, Teo W, &, Poeschla EM, (2006) An essential role for LEDGF/p75 in HIV integration. Science 314, 461-464. (Pubitemid 44628966)
71. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, Debyser Z, &, Engelborghs Y, (2003) LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 278, 33528-33539. (Pubitemid 37055807)
72. Cherepanov P, Devroe E, Silver PA, &, Engelman A, (2004) Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV 1-integrase. J Biol Chem 279, 48883-48892. (Pubitemid 39625769)
73. De Rijck J, Vandekerckhove L, Gijsbers R, Hombrouck A, Hendrix J, Vercammen J, Engelborghs Y, Christ F, &, Debyser Z, (2006) Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication. J Virol 80, 11498-11509. (Pubitemid 44788865)
74. Benyamini H, &, Friedler A, (2010) Using peptides to study protein-protein interactions. Future Med Chem 2, 989-1003.
75. Hayouka Z, Rosenbluh J, Levin A, Loya S, Lebendiker M, Veprintsev D, Kotler M, Hizi A, Loyter A, &, Friedler A, (2007) Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proc Natl Acad Sci USA 104, 8316-8321. (Pubitemid 47175485)
76. Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, &, Friedler A, (2010) Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370. Biochem Biophys Res Commun 394, 260-265.
77. Hayouka Z, Hurevich M, Levin A, Benyamini H, Iosub A, Maes M, Shalev DE, Loyter A, Gilon C, &, Friedler A, (2010) Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein. Bioorg Med Chem 18, 8388-8395.
78. Al-Mawsawi LQ, Christ F, Dayam R, Debyser Z, &, Neamati N, (2008) Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis. FEBS Lett 582, 1425-1430.
79. Rhodes DI, Peat TS, Vandegraaff N, Jeevarajah D, Newman J, Martyn J, Coates JA, Ede NJ, Rea P, &, Deadman JJ, (2011) Crystal structures of novel allosteric peptide inhibitors of HIV integrase identify new interactions at the LEDGF binding site. ChemBioChem in press. doi:10.1002/cbic.201100350.
80. Tsiang M, Jones GS, Hung M, Mukund S, Han B, Liu X, Babaoglu K, Lansdon E, Chen X, Todd J, et al., (2009) Affinities between the binding partners of the HIV-1 integrase dimer-lens epithelium-derived growth factor (IN dimer-LEDGF) complex. J Biol Chem 284, 33580-33599.
81. Tsiang M, Jones GS, Hung M, Samuel D, Novikov N, Mukund S, Brendza KM, Niedziela-Majka A, Jin D, Liu X, et al., (2011) Dithiothreitol causes HIV-1 integrase dimer dissociation while agents interacting with the integrase dimer interface promote dimer formation. Biochemistry 50, 1567-1581.
82. Wilkinson TA, Januszyk K, Phillips ML, Tekeste SS, Zhang M, Miller JT, Le Grice SF, Clubb RT, &, Chow SA, (2009) Identifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase. J Biol Chem 284, 7931-7939.
83. Zhu K, Dobard C, &, Chow SA, (2004) Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase. J Virol 78, 5045-5055. (Pubitemid 38581456)
84. Oz I, Avidan O, &, Hizi A, (2002) Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases. Biochem J 361, 557-566. (Pubitemid 34177825)
85. Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, &, Hizi A, (2005) Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase. J Biol Chem 280, 21987-21996. (Pubitemid 40827852)
86. Zawahir Z, &, Neamati N, (2006) Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. Bioorg Med Chem Lett 16, 5199-5202. (Pubitemid 44247685)
87. Kogan M, &, Rappaport J, (2011) HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology 8, 25. doi:10.1186/1742-4690-8-25.
88. Gleenberg IO, Herschhorn A, &, Hizi A, (2007) Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr). J Mol Biol 369, 1230-1243. (Pubitemid 46770767)
89. Morellet N, Bouaziz S, Petitjean P, &, Roques BP, (2003) NMR structure of the HIV-1 regulatory protein VPR. J Mol Biol 327, 215-227. (Pubitemid 36293314)
90. Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, &, Hamatake M, (2010) Peptide HIV-1 integrase inhibitors from HIV-1 gene products. J Med Chem 53, 5356-5360.
91. Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, et al., (2010) Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies. Bioorg Med Chem 18, 6771-6775.
92. Grewe B, &, Uberla K, (2010) The human immunodeficiency virus type 1 Rev protein: menage a trois during the early phase of the lentiviral replication cycle. J Gen Virol 91, 1893-1897.
93. Levin A, Hayouka Z, Brack-Werner R, Volsky DJ, Friedler A, &, Loyter A, (2009) Novel regulation of HIV-1 replication and pathogenicity: rev inhibition of integration. Protein Eng Des Sel 22, 753-763.
94. Hayouka Z, Rosenbluh J, Levin A, Maes M, Loyter A, &, Friedler A, (2008) Peptides derived from HIV-1 Rev inhibit HIV-1 integrase in a shiftide mechanism. Biopolymers 90, 481-487.
95. Levin A, Hayouka Z, Helfer M, Brack-Werner R, Friedler A, &, Loyter A, (2009) Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration. PLoS ONE 4, e4155.
96. Benyamini H, Loyter A, &, Friedler A, (2011) A structural model of the HIV-1 Rev-integrase complex: the molecular basis of integrase regulation by Rev. Biochem Biophys Res Commun 416, 252-257.
97. Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, &, Plasterk RH, (1995) Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library. Proc Natl Acad Sci USA 92, 11456-11460. (Pubitemid 26014132)
98. Desjobert C, de Soultrait VR, Faure A, Parissi V, Litvak S, Tarrago-Litvak L, &, Fournier M, (2004) Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase. Biochemistry, 43, 13097-13105. (Pubitemid 39362779)
99. de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, &, Roques B, (2002) A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase. J Mol Biol 318, 45-58. (Pubitemid 34729384)
100. Hu JP, Gong XQ, Su JG, Chen WZ, &, Wang CX, (2008) Study on the molecular mechanism of inhibiting HIV-1 integrase by EBR28 peptide via molecular modeling approach. Biophys Chem 132, 69-80. (Pubitemid 350251878)
101. Armon-Omer A, Levin A, Hayouka Z, Butz K, Hoppe-Seyler F, Loya S, Hizi A, Friedler A, &, Loyter A, (2008) Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library. J Mol Biol 376, 971-982.
102. Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, &, Friedler A, (2009) Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds. Bioorg Med Chem 17, 7635-7642.
103. Singh SB, Zink DL, Heimbach B, Genilloud O, Teran A, Silverman KC, Lingham RB, Felock P, &, Hazuda DJ, (2002) Structure, stereochemistry, and biological activity of integramycin, a novel hexacyclic natural product produced by Actinoplanes sp. that inhibits HIV-1 integrase. Org Lett 4, 1123-1126.
104. De Zotti M, Formaggio F, Kaptein B, Broxterman QB, Felock PJ, Hazuda DJ, Singh SB, Bruckner H, &, Toniolo C, (2009) Complete absolute configuration of integramide A, a natural, 16-mer peptide inhibitor of HIV-1 integrase, elucidated by total synthesis. ChemBioChem 10, 87-90.
105. De Zotti M, Damato F, Formaggio F, Crisma M, Schievano E, Mammi S, Kaptein B, Broxterman QB, Felock PJ, Hazuda DJ, et al., (2010) Total synthesis, characterization, and conformational analysis of the naturally occurring hexadecapeptide integramide A and a diastereomer. Chemistry 16, 316-327.
106. De Zotti M, De Borggraeve W, Kaptein B, Broxterman QB, Singh SB, Felock PJ, Hazuda DJ, Formaggio F, &, Toniolo C, (2010) Triple Hyp - >Pro replacement in integramide A, a peptaib inhibitor of HIV-1 integrase: effect on conformation and bioactivity. Biopolymers 96, 49-59.
107. Singh SB, Jayasuriya H, Salituro GM, Zink DL, Shafiee A, Heimbuch B, Silverman KC, Lingham RB, Genilloud O, Teran A, et al., (2001) The complestatins as HIV-1 integrase inhibitors. Efficient isolation, structure elucidation, and inhibitory activities of isocomplestatin, chloropeptin I, new complestatins, A and B, and acid-hydrolysis products of chloropeptin I. J Nat Prod 64, 874-882. (Pubitemid 32729896)
108. Robinson WE Jr, McDougall B, Tran D, &, Selsted ME, (1998) Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. J Leukoc Biol 63, 94-100. (Pubitemid 28070387)
109. Krajewski K, Marchand C, Long YQ, Pommier Y, &, Roller PP, (2004) Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin. Bioorg Med Chem Lett 14, 5595-5598. (Pubitemid 39346352)
110. Marchand C, Krajewski K, Lee HF, Antony S, Johnson AA, Amin R, Roller P, Kvaratskhelia M, &, Pommier Y, (2006) Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Res 34, 5157-5165. (Pubitemid 44742480)
111. Krajewski K, Long YQ, Marchand C, Pommier Y, &, Roller PP, (2003) Design and synthesis of dimeric HIV-1 integrase inhibitory peptides. Bioorg Med Chem Lett 13, 3203-3205. (Pubitemid 37093828)
112. Elyakova LA, Vaskovsky BV, Khoroshilova NI, Vanteseva SI, &, Agapkina YY, (2011) Isolation and structure of a novel peptide inhibitor of HIV-1 integrase from marine polychaetes. Russ J Bioorg Chem 37, 207-216.
113. Ren J, Milton J, Weaver KL, Short SA, Stuart DI, &, Stammers DK, (2000) Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase. Structure 8, 1089-1094. (Pubitemid 32667472)
114. de Soultrait VR, Lozach PY, Altmeyer R, Tarrago-Litvak L, Litvak S, &, Andreola ML, (2002) DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents. J Mol Biol 324, 195-203. (Pubitemid 35379020)